Videos

Icon Bioscience

By Tom Salemi | June 8, 2015

The company’s proprietary Verisome drug delivery technology is being used as the base for IBI-10090, for post-cataract surgery inflammation. The dexamethasone compound completed a pivotal…

Read More

Kala Therapeutics

By Tom Salemi | June 8, 2015

By penetrating the mucosal barrier in the eye, Kala’s Mucosal Penetrating Products (MPPs) “enhances pharmacokinetics” and can be used to treat both anterior and posterior…

Read More

Envisia Therapeutics

By Tom Salemi | June 8, 2015

ENV515 is a proprietary, fully biodegradable PRINT (Particle Replication In Non-Wetting Templates) particle formulation of a prostaglandin analog, travoprost, with the potential for sustained intraocular…

Read More

Glaukos

By Tom Salemi | June 5, 2015

The $4.9 billion glaucoma market is expected to reach $6.6 billion by 2019. The company launched its first product, the iStent, about 2 years ago…

Read More

Spotlight on MIGS – Market Overview

By Tom Salemi | June 5, 2015

Participant: Eric Donnenfeld, MD Eric Donnenfeld, MD is a founding partner of Ophthalmic Consultants of Long Island, Professor of Ophthalmology NYU and a Trustee at…

Read More

Ivantis

By Tom Salemi | June 5, 2015

The Hydrus Microstent dilates and scaffolds Schlemm’s canal. More than 2,000 people in 21 countries have been treated with the Hydrus, and recruitment for the…

Read More

Transcend Medical

By Tom Salemi | June 5, 2015

The CyPass Micro-Stent has been implanted in more than 1,000 patients over the course of 10 years as part of multiple clinical trials, and Transcend…

Read More

Spotlight on MIGS

By Tom Salemi | June 5, 2015

Participants: Eric Donnenfeld, MD Eric Donnenfeld, MD is a founding partner of Ophthalmic Consultants of Long Island, Professor of Ophthalmology NYU and a Trustee at…

Read More

Spotlight on Pressure Reduction – Market Overview

By Tom Salemi | June 5, 2015

Participant: Kuldev Singh, MD, MPH Dr. Kuldev Singh is Professor of Ophthalmology and Director of the Glaucoma Service at the Stanford University School of Medicine.…

Read More

Jade Therapeutics

By Tom Salemi | June 5, 2015

Jade’s proprietary, cross-linked, bioerodable hydrogel technology can be used alone as an ocular lubricant, or as a sustained-release vehicle for either anterior or posterior segments.…

Read More

MicroOptx

By Tom Salemi | June 5, 2015

The company’s BG implant shunts aqueous to the tear film without risk of internal infection, and has developed a successful prototype with both bench and…

Read More

LacriScience

By Tom Salemi | June 5, 2015

The company’s LacriPen is a handheld, portable, diagnostic tool that measures osmolarity to within 2 mOsml. It uses a technique called surface plasma residence, which…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.